Mangoceuticals, inc. completes acquisition of mushroom-based wellness and innovations patent

Dallas, tx, dec. 19, 2024 (globe newswire) -- mangoceuticals, inc. (nasdaq: mgrx) (“mangorx” or the “company”), a company focused on developing, marketing, and selling men's health and wellness products via a secure telemedicine platform, today announced the acquisition of patent number wo 2023/086647 pct/us2022/049857, for mushroom-derived compositions and methods of treatment. this new addition to mangorx's intellectual property portfolio highlights the company's commitment to innovative solutions that support holistic health and wellness.
MGRX Ratings Summary
MGRX Quant Ranking